214 related articles for article (PubMed ID: 38286657)
1. Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinoma.
Caeiro LD; Nakata Y; Borges RL; Zha M; Garcia-Martinez L; Bañuelos CP; Stransky S; Liu T; Chan HL; Brabson J; Domínguez D; Zhang Y; Lewis PW; Aznar Benitah S; Cimmino L; Bilbao D; Sidoli S; Wang Z; Verdun RE; Morey L
Genes Dev; 2024 Feb; 38(1-2):46-69. PubMed ID: 38286657
[TBL] [Abstract][Full Text] [Related]
2. Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinoma.
Caeiro LD; Nakata Y; Borges RL; Garcia-Martinez L; Bañuelos CP; Stransky S; Chan HL; Brabson J; Domínguez D; Zhang Y; Lewis PW; Aznar-Benitah S; Cimmino L; Bilbao D; Sidoli S; Verdun RE; Morey L
bioRxiv; 2023 Nov; ():. PubMed ID: 38076924
[TBL] [Abstract][Full Text] [Related]
3. Depletion of H3K36me2 recapitulates epigenomic and phenotypic changes induced by the H3.3K36M oncohistone mutation.
Rajagopalan KN; Chen X; Weinberg DN; Chen H; Majewski J; Allis CD; Lu C
Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33619101
[TBL] [Abstract][Full Text] [Related]
4. The Emerging Significance of Histone Lysine Demethylases as Prognostic Markers and Therapeutic Targets in Head and Neck Cancers.
Dorna D; Paluszczak J
Cells; 2022 Mar; 11(6):. PubMed ID: 35326475
[TBL] [Abstract][Full Text] [Related]
5. Recognition of cancer mutations in histone H3K36 by epigenetic writers and readers.
Klein BJ; Krajewski K; Restrepo S; Lewis PW; Strahl BD; Kutateladze TG
Epigenetics; 2018; 13(7):683-692. PubMed ID: 30045670
[TBL] [Abstract][Full Text] [Related]
6. Chromatin dysregulation associated with NSD1 mutation in head and neck squamous cell carcinoma.
Farhangdoost N; Horth C; Hu B; Bareke E; Chen X; Li Y; Coradin M; Garcia BA; Lu C; Majewski J
Cell Rep; 2021 Feb; 34(8):108769. PubMed ID: 33626351
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis for the role of oncogenic histone mutations in modulating H3K36 methylation.
Zhang Y; Shan CM; Wang J; Bao K; Tong L; Jia S
Sci Rep; 2017 Mar; 7():43906. PubMed ID: 28256625
[TBL] [Abstract][Full Text] [Related]
8. Global histone H3 lysine 27 triple methylation levels are reduced in vessels with advanced atherosclerotic plaques.
Wierda RJ; Rietveld IM; van Eggermond MC; Belien JA; van Zwet EW; Lindeman JH; van den Elsen PJ
Life Sci; 2015 May; 129():3-9. PubMed ID: 25445221
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation.
Gannon OM; Merida de Long L; Endo-Munoz L; Hazar-Rethinam M; Saunders NA
Clin Cancer Res; 2013 Jan; 19(2):428-41. PubMed ID: 23186778
[TBL] [Abstract][Full Text] [Related]
10. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract][Full Text] [Related]
11. Targeting KDM2A Enhances T-cell Infiltration in NSD1-Deficient Head and Neck Squamous Cell Carcinoma.
Chen C; Shin JH; Fang Z; Brennan K; Horowitz NB; Pfaff KL; Welsh EL; Rodig SJ; Gevaert O; Gozani O; Uppaluri R; Sunwoo JB
Cancer Res; 2023 Aug; 83(16):2645-2655. PubMed ID: 37311054
[TBL] [Abstract][Full Text] [Related]
12. Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas.
Papillon-Cavanagh S; Lu C; Gayden T; Mikael LG; Bechet D; Karamboulas C; Ailles L; Karamchandani J; Marchione DM; Garcia BA; Weinreb I; Goldstein D; Lewis PW; Dancu OM; Dhaliwal S; Stecho W; Howlett CJ; Mymryk JS; Barrett JW; Nichols AC; Allis CD; Majewski J; Jabado N
Nat Genet; 2017 Feb; 49(2):180-185. PubMed ID: 28067913
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathways: deregulation of histone h3 lysine 27 methylation in cancer-different paths, same destination.
Ezponda T; Licht JD
Clin Cancer Res; 2014 Oct; 20(19):5001-8. PubMed ID: 24987060
[TBL] [Abstract][Full Text] [Related]
14. Histone 3 lysine 36 to methionine mutations stably interact with and sequester SDG8 in Arabidopsis thaliana.
Lin G; Zhou Y; Li M; Fang Y
Sci China Life Sci; 2018 Feb; 61(2):225-234. PubMed ID: 28975546
[TBL] [Abstract][Full Text] [Related]
15. H3K27me3 is an epigenetic barrier while KDM6A overexpression improves nuclear reprogramming efficiency.
Zhou C; Wang Y; Zhang J; Su J; An Q; Liu X; Zhang M; Wang Y; Liu J; Zhang Y
FASEB J; 2019 Mar; 33(3):4638-4652. PubMed ID: 30673507
[TBL] [Abstract][Full Text] [Related]
16. Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape.
Lu C; Jain SU; Hoelper D; Bechet D; Molden RC; Ran L; Murphy D; Venneti S; Hameed M; Pawel BR; Wunder JS; Dickson BC; Lundgren SM; Jani KS; De Jay N; Papillon-Cavanagh S; Andrulis IL; Sawyer SL; Grynspan D; Turcotte RE; Nadaf J; Fahiminiyah S; Muir TW; Majewski J; Thompson CB; Chi P; Garcia BA; Allis CD; Jabado N; Lewis PW
Science; 2016 May; 352(6287):844-9. PubMed ID: 27174990
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional specificity of H3K36 methylation.
Lam UTF; Tan BKY; Poh JJX; Chen ES
Epigenetics Chromatin; 2022 May; 15(1):17. PubMed ID: 35581654
[TBL] [Abstract][Full Text] [Related]
18. Impact of Epigenetic Regulation on Head and Neck Squamous Cell Carcinoma.
Bais MV
J Dent Res; 2019 Mar; 98(3):268-276. PubMed ID: 30615537
[TBL] [Abstract][Full Text] [Related]
19. NSD1 supports cell growth and regulates autophagy in HPV-negative head and neck squamous cell carcinoma.
Topchu I; Bychkov I; Gursel D; Makhov P; Boumber Y
bioRxiv; 2023 Sep; ():. PubMed ID: 37786686
[TBL] [Abstract][Full Text] [Related]
20. Resetting the histone code at CDKN2A in HNSCC by inhibition of DNA methylation.
Coombes MM; Briggs KL; Bone JR; Clayman GL; El-Naggar AK; Dent SY
Oncogene; 2003 Dec; 22(55):8902-11. PubMed ID: 14654786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
